These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 15877999)
1. Effect of nifedipine on C-reactive protein levels in the coronary sinus and on coronary blood flow in response to acetylcholine in patients with stable angina pectoris having percutaneous coronary intervention. Takase H; Toriyama T; Sugiyama M; Nakazawa A; Hayashi K; Goto T; Sugiura T; Ikeda K; Sato K; Ueda R; Dohi Y Am J Cardiol; 2005 May; 95(10):1235-7. PubMed ID: 15877999 [TBL] [Abstract][Full Text] [Related]
2. Rapid effect of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition on coronary endothelial function. Wassmann S; Faul A; Hennen B; Scheller B; Böhm M; Nickenig G Circ Res; 2003 Oct; 93(9):e98-103. PubMed ID: 14551237 [TBL] [Abstract][Full Text] [Related]
3. Relation between C reactive protein concentrations and coronary microvascular endothelial function. Teragawa H; Fukuda Y; Matsuda K; Ueda K; Higashi Y; Oshima T; Yoshizumi M; Chayama K Heart; 2004 Jul; 90(7):750-4. PubMed ID: 15201242 [TBL] [Abstract][Full Text] [Related]
4. Beneficial effects of nifedipine on vasodilator response to acetylcholine in coronary and brachial arteries in the patients with coronary artery disease. Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A Int J Cardiol; 2006 Nov; 113(3):305-10. PubMed ID: 16386809 [TBL] [Abstract][Full Text] [Related]
5. A randomized placebo-controlled study on the effect of nifedipine on coronary endothelial function and plaque formation in patients with coronary artery disease: the ENCORE II study. Lüscher TF; Pieper M; Tendera M; Vrolix M; Rutsch W; van den Branden F; Gil R; Bischoff KO; Haude M; Fischer D; Meinertz T; Münzel T Eur Heart J; 2009 Jul; 30(13):1590-7. PubMed ID: 19474053 [TBL] [Abstract][Full Text] [Related]
6. Myocardial perfusion reserve in cardiovascular magnetic resonance: Correlation to coronary microvascular dysfunction. Wöhrle J; Nusser T; Merkle N; Kestler HA; Grebe OC; Marx N; Höher M; Kochs M; Hombach V J Cardiovasc Magn Reson; 2006; 8(6):781-7. PubMed ID: 17060099 [TBL] [Abstract][Full Text] [Related]
7. A case of vasospastic angina showing resolution of coronary vasospasm in acetylcholine provocation test corresponding to regression of coronary atherosclerosis. Tani S; Watanabe I; Anazawa T; Kawamata H; Tachibana E; Fuji T; Matsumoto M; Onikura M; Sato Y; Nagao K; Kanmatsuse K; Kushiro T; Hirayama A Int J Cardiol; 2008 Mar; 125(1):e1-3. PubMed ID: 17379335 [TBL] [Abstract][Full Text] [Related]
8. Acetylcholine-induced coronary spasm in patients with unobstructed coronary arteries is associated with elevated concentrations of soluble CD40 ligand and high-sensitivity C-reactive protein. Ong P; Carro A; Athanasiadis A; Borgulya G; Schäufele T; Ratge D; Gaze D; Sechtem U; Kaski JC Coron Artery Dis; 2015 Mar; 26(2):126-32. PubMed ID: 25405929 [TBL] [Abstract][Full Text] [Related]
9. Elevated C-reactive protein levels and coronary microvascular dysfunction in patients with coronary artery disease. Tomai F; Ribichini F; Ghini AS; Ferrero V; Andò G; Vassanelli C; Romeo F; Crea F; Chiariello L Eur Heart J; 2005 Oct; 26(20):2099-105. PubMed ID: 15961409 [TBL] [Abstract][Full Text] [Related]
10. Coronary and aortic calcifications inter-relationship in stable angina pectoris: A Coronary Disease Trial Investigating Outcome with Nifedipine GITS (ACTION)--Israeli spiral computed tomography substudy. Eisen A; Tenenbaum A; Koren-Morag N; Tanne D; Shemesh J; Golan A; Fisman EZ; Motro M; Schwammenthal E; Adler Y Isr Med Assoc J; 2007 Apr; 9(4):277-80. PubMed ID: 17491221 [TBL] [Abstract][Full Text] [Related]
11. Coronary vasomotor response is related to the angiographic extent of coronary sclerosis in patients with stable angina pectoris. Asselbergs FW; Monnink SH; Veeger NJ; van Boven AJ; van Haelst PL; Jessurun GA; van Gilst WH; Tio RA Clin Sci (Lond); 2004 Feb; 106(2):115-20. PubMed ID: 12956627 [TBL] [Abstract][Full Text] [Related]
12. [Acute coronary vasomotor effects of nifedipine and its therapeutic efficacy in syndrome X]. Montorsi P; Cozzi S; Loaldi A; Fabbiocchi F; Annoni L; De Cesare N; Polese A; Guazzi MD Cardiologia; 1990 Oct; 35(10):851-6. PubMed ID: 2093432 [TBL] [Abstract][Full Text] [Related]
13. Effects of intracoronary felodipine versus nifedipine on left ventricular contractility and coronary sinus blood flow in stable angina pectoris. Koolen JJ; Van Wezel HB; Piek J; van Liebergen R; Swaan A; Visser CA Am J Cardiol; 1994 Oct; 74(7):730-2. PubMed ID: 7942536 [No Abstract] [Full Text] [Related]
14. Impact of coronary angioplasty on coronary vasodilator response of normal nondilated coronary arteries in patients with stable angina. Foley JB; Watson KR; Chisholm RJ Am J Cardiol; 1995 May; 75(15):1070-1. PubMed ID: 7747693 [No Abstract] [Full Text] [Related]
16. Close relationship between the vasodilator response to acetylcholine in the brachial and coronary artery in suspected coronary artery disease. Takase B; Hamabe A; Satomura K; Akima T; Uehata A; Ohsuzu F; Ishihara M; Kurita A Int J Cardiol; 2005 Oct; 105(1):58-66. PubMed ID: 16207546 [TBL] [Abstract][Full Text] [Related]
17. Pregnancy-associated plasma protein A and its endogenous inhibitor, the proform of eosinophil major basic protein (proMBP), are related to complex stenosis morphology in patients with stable angina pectoris. Cosin-Sales J; Christiansen M; Kaminski P; Oxvig C; Overgaard MT; Cole D; Holt DW; Kaski JC Circulation; 2004 Apr; 109(14):1724-8. PubMed ID: 15023879 [TBL] [Abstract][Full Text] [Related]
18. Different coronary vasomotor effects of nifedipine and therapeutic correlates in angina with spontaneous and effort components versus Prinzmetal angina. Loaldi A; Fabbiocchi F; Montorsi P; De Cesare N; Bartorelli A; Polese A; Guazzi MD Am Heart J; 1989 Feb; 117(2):315-22. PubMed ID: 2916407 [TBL] [Abstract][Full Text] [Related]
19. Correlates of coronary angiography in patients with stable angina and geographical differences in its utilisation: the ACTION experience. Vokó Z; Danchin N; de Brouwer S; Kirwan BA; Poole-Wilson PA; Lubsen J; Int J Cardiol; 2010 Jan; 138(1):56-62. PubMed ID: 18845347 [TBL] [Abstract][Full Text] [Related]